The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes: Table 1
Open accessAbstract
In recent years the use of radiation treatment for benign tumours has increased with the advent of stereotactic delivery and, in particular, single high dose gamma knife therapy. This has been particularly true for benign CNS (central nervous system) tumours such as vestibular schwannoma, meningioma, pituitary adenoma, and haemangioblastoma. While short term follow up in patients with isolated tumours suggests this treatment is safe, there are particular concerns regarding its use in childhood and in tumour predisposing syndromes. We have reviewed the use of radiation treatment in these contexts with particular regard to malignant transformation and new tumour induction. This review indicates that much more caution is warranted regarding the use of radiation treatment for benign tumours in childhood and in tumour prone conditions such as the neurofibromatoses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries
de González, A. B., & Darby, S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15433-0 · Cited by 1,718
Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases
Ducatman, B. S., Scheithauer, B. W., Piepgras, D. G., Reiman, H. M., & Ilstrup, D. M. (1986) · Cancer · doi:10.1002/1097-0142(19860515)57:10<2006::aid-cncr2820571022>3.0.co;2-6 · Cited by 1,581
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
Evans, D. G. R., Baser, M. E., McGaughran, J., Sharif, S., Howard, E., & Moran, A. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.5.311 · Cited by 1,282
Self-citationTumors of the Brain and Nervous System after Radiotherapy in Childhood
Ron, E., Modan, B., Boice, J. D., Alfandary, E., Stovall, M., Chetrit, A., & Katz, L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810203191601 · Cited by 934
Nevoid Basal-Cell Carcinoma Syndrome
GORLIN, R. J. (1987) · Medicine · doi:10.1097/00005792-198703000-00002 · Cited by 883
Neglia, J. P., Friedman, D. L., Yasui, Y., Mertens, A. C., Hammond, S., Stovall, M., Donaldson, S. S., Meadows, A. T., & Robison, L. L. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.8.618 · Cited by 741
Breast and Other Cancers in Families with Ataxia-Telangiectasia
Swift, M., Reitnauer, P. J., Morrell, D., & Chase, C. L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705213162101 · Cited by 719
Second primary neoplasms in patients with retinoblastoma
Draper, G. J., Sanders, B. M., & Kingston, J. E. (1986) · British Journal of Cancer · doi:10.1038/bjc.1986.110 · Cited by 554
Fei, P., & El-Deiry, W. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206677 · Cited by 498
Relative frequency and morphology of cancers in carriers of germline TP53 mutations
Birch, J. M., Alston, R. D., McNally, R. J., Evans, D. G. R., Kelsey, A. M., Harris, M., Eden, O. B., & Varley, J. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204621 · Cited by 467
Self-citationRisk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.
Brada, M., Ford, D., Ashley, S., Bliss, J. M., Crowley, S., Mason, M., Rajan, B., & Traish, D. (1992) · BMJ · doi:10.1136/bmj.304.6838.1343 · Cited by 413
CANCER RISKS FROM MEDICAL RADIATION
Ron, E. (2003) · Health Physics · doi:10.1097/00004032-200307000-00011 · Cited by 382
Sharif, S., Ferner, R., Birch, J. M., Gillespie, J. E., Gattamaneni, H. R., Baser, M. E., & Evans, D. G. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8349 · Cited by 377
Self-citationIncidence of second primary tumours among childhood cancer survivors
Hawkins, M., Draper, G., & Kingston, J. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.200 · Cited by 332
Optic gliomas in children with neurofibromatosis type 1
Listernick, R., Charrow, J., Greenwald, M. J., & Esterly, N. B. (1989) · The Journal of Pediatrics · doi:10.1016/s0022-3476(89)80137-4 · Cited by 307
Guillamo, J.-S., Creange, A., Kalifa, C., Grill, J., Rodriguez, D., Doz, F., Barbarot, S., Zerah, M., Sanson, M., Bastuji-Garin, S., et al. (2003) · Brain · doi:10.1093/brain/awg016 · Cited by 295
Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors
Varley, J. M., McGown, G., Thorncroft, M., James, L. A., Margison, G. P., Forster, G., Evans, D. G. R., Harris, M., Kelsey, A. M., & Birch, J. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302575 · Cited by 266
Self-citationA genetic register for von Hippel-Lindau disease.
Maddock, I. R., Moran, A., Maher, E. R., Teare, M. D., Norman, A., Payne, S. J., Whitehouse, R., Dodd, C., Lavin, M., Hartley, N., et al. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.2.120 · Cited by 263
Self-citationManagement of the patient and family with neurofibromatosis 2: a consensus conference statement
Evans, D., Baser, M., O'Reilly, B., Rowe, J., Gleeson, M., Saeed, S., King, A., Huson, S., Kerr, R., Thomas, N., et al. (2005) · British Journal of Neurosurgery · doi:10.1080/02688690500081206 · Cited by 261
Self-citationPrediction of pathogenic mutations in patients with early-onset breast cancer by family history
Lalloo, F., Varley, J., Ellis, D., Moran, A., O'Dair, L., Pharoah, P., & Evans, D. G. R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12856-5 · Cited by 202
Self-citationRoberts, S. A., Spreadborough, A. R., Bulman, B., Barber, J. B. P., Evans, D. G. R., & Scott, D. (1999) · The American Journal of Human Genetics · doi:10.1086/302544 · Cited by 197
Self-citationHeyn, R., Haeberlen, V, Newton, W. A., Ragab, A. H., Raney, R. B., Tefft, M., Wharam, M., Ensign, L. G., & Maurer, H. M. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.2.262 · Cited by 192
Malignant Breast Tumors Among Atomic Bomb Survivors, Hiroshima and Nagasaki, 1950–1974
Tokunaga, M., Norman, J. E., Masahide Asano, M. D., et al. (1979) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/62.6.1347 · Cited by 157
Garwicz, S., Anderson, H., Olsen, J. H., D�llner, H., HERTZ, H., Jónmundsson, G., Langmark, F., Lanning, M., M�ller, T., Sankila, R. J., et al. (2000) · International Journal of Cancer · Cited by 156
Two metachronous tumors in the radiotherapy fields of a patient with Li‐Fraumeni syndrome
Limacher, J., Frébourg, T., Natarajan‐Amé, S., & Bergerat, J. (2001) · International Journal of Cancer · doi:10.1002/ijc.1021 · Cited by 151
de Vathaire, F., Hawkins, M. M., Campbell, S., Oberlin, O., Raquin, M. A., Schlienger, J.-Y., Shamsaldin, A., Diallo, I., Bell, J., Grimaud, E., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690300 · Cited by 150
Neurofibromatosis type 1 and sporadic optic gliomas
Singhal, S. (2002) · Archives of Disease in Childhood · doi:10.1136/adc.87.1.65 · Cited by 141
Rosen, E. M., Fan, S., Rockwell, S., & Goldberg, I. D. (1999) · Cancer Investigation · doi:10.1080/07357909909011718 · Cited by 134
Genetic and environmental interactions
Strong, L. C. (1977) · Cancer · Cited by 119
Long‐term risk of second malignant neoplasms after neuroblastoma in childhood: Role of treatment
Rubino, C., Adjadj, É., Guérin, S., Guibout, C., Shamsaldin, A., Dondon, M., Valteau‐Couanet, D., Hartmann, O., Hawkins, M., & de Vathaire, F. (2003) · International Journal of Cancer · doi:10.1002/ijc.11455 · Cited by 87
Clark, G. M. (1994) · Minerva Access (University of Melbourne) · Cited by 84
Birch, J. M. (1999) · Archives of Disease in Childhood · doi:10.1136/adc.80.1.1 · Cited by 79
Self-citationIs there an increase in second brain tumours after surgery and irradiation for a pituitary tumour?
Erfurth, E. M., Bülow, B., Mikoczy, Z., Svahn‐Tapper, G., & Hagmar, L. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01385.x · Cited by 74
Malignant transformation of a recurrent vestibular schwannoma
Wilkinson, J. S., Reid, H., & Armstrong, G. R. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.57.1.109 · Cited by 61
Chromosome instability is a predominant trait of fibroblasts from Li-Fraumeni families
Boyle, J. M., Mitchell, E. L. D., Greaves, M. J., Roberts, S., Tricker, K. J., Burt, E., Varley, J. M., Birch, J. M., & Scott, D. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.364 · Cited by 49
Self-citationNutting, C. M., Camplejohn, R., Gilchrist, R., Tait, D., Blake, P., Knee, G., Yao, W. Q., Ross, G., Fisher, C., & Eeles, R. A. (2000) · Clinical Oncology · doi:10.1053/clon.2000.9179 · Cited by 44
Price (1999) · doi:10.1002/1531-8249(199903)45:3
Cited by
Asthagiri, A. R., Parry, D. M., Butman, J. A., Kim, H. J., Tsilou, E. T., Zhuang, Z., & Lonser, R. R. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60259-2 · Cited by 665
Optic pathway gliomas in neurofibromatosis‐1: Controversies and recommendations
Listernick, R., Ferner, R. E., Liu, G. T., & Gutmann, D. H. (2007) · Annals of Neurology · doi:10.1002/ana.21107 · Cited by 576
Mai, P. L., Best, A. F., Peters, J. A., DeCastro, R. M., Khincha, P. P., Loud, J. T., Bremer, R. C., Rosenberg, P. S., & Savage, S. A. (2016) · Cancer · doi:10.1002/cncr.30248 · Cited by 486
Radiation therapy‐associated toxicity: Etiology, management, and prevention
Wang, K., & Tepper, J. E. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21689 · Cited by 449
Sharif, S., Ferner, R., Birch, J. M., Gillespie, J. E., Gattamaneni, H. R., Baser, M. E., & Evans, D. G. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8349 · Cited by 377
Self-citation
Metadata
- Authors
- Evans, D. G. R., Birch, J. M., Ramsden, R. T., Sharif, S., & Baser, M. E.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 2005-09-09
- Volume
- 43
- Issue
- 4
- Pages
- 289-294
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W2125259518
- Cited by
- 301
- References
- 37
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.